Socel: Social for the Animation Arts

Tobias Ernst<a href="https://bsky.brid.gy/ap/did:plc:x7vfp7rt4gbywara7ljm5e2s" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@volksverpetzer.de</a> Mit Verlaub. Als <a href="https://friendica.tf-translate.net/search?tag=Impfschaden" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Impfschaden</a> werden nur die direkten Impfschäden gezählt und selbst da ist Anerkennung extrem schwer zu erreichen, da sehr viele Ärzte gar nicht bereit waren, entsprechende Meldungen zu machen (Überforderung, zu viel Bürkokratie, Angst um eigene Reputation, etc.). Die indirekten Impfschäden (in engem zeitlichen Zusammenhang mit <a href="https://friendica.tf-translate.net/search?tag=Corona" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Corona</a> Vakzination erfolgter Ausbruch einer vorher schlafenden chronifizierten Infektion wie <a href="https://friendica.tf-translate.net/search?tag=Borreliose" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Borreliose</a>, <a href="https://friendica.tf-translate.net/search?tag=Zoster" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Zoster</a>, <a href="https://friendica.tf-translate.net/search?tag=EBV%29" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV)</a> haben es nie in irgendwelche Register geschafft, werden von ihren Hausärzten gegaslighted und müssen ihre Behandlung meist aus der eigenen Tasche bezahlen oder siechen dahin. Weiß das, da ich mehrere Betroffene in der Familie habe, wohingegen der einzige Corona-Tote, den ich kannte, geimpft war. Nur weil die rechten Schwurbler die lautesten Kritker der Coronapolitik waren, heißt das nicht, dass an der Coronaimpfung alles Gold ist, was als glänzend dargestellt wurde. Was mich stört, ist, dass die bei jeder <a href="https://friendica.tf-translate.net/search?tag=Impfung" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Impfung</a> erforderliche individuelle Nutzen-Risiko-Abwägung völlig außer Kraft gesetzt wurde. Genau diese Herangehensweise war erst recht Wasser auf die Mühlen der rechten Schwurbler.

Tom KindlonFrom ME Research UKME Research UK has a number of research summaries exploring possible links between Epstein-Barr Virus (EBV) and ME/CFS, including its possible role in triggering the disease, potential diagnostic markers, and insights from related conditions.Read more - <a href="https://bit.ly/EBVandME" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://bit.ly/EBVandME</a><a href="https://disabled.social/tags/mecfs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#mecfs</a> <a href="https://a.gup.pe/u/mecfs" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@mecfs</a> <a href="https://disabled.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a>

AuscandocDoctors Uncover How a Dormant Virus Reactivates After COVID and Triggers Severe Illness in Kids <a href="https://scitechdaily.com/doctors-uncover-how-a-dormant-virus-reactivates-after-covid-and-triggers-severe-illness-in-kids/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://scitechdaily.com/doctors-uncover-how-a-dormant-virus-reactivates-after-covid-and-triggers-severe-illness-in-kids/</a> <a href="https://med-mastodon.com/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> is really the virus that just keeps on giving us nasty stuff.

Charité Berlin‼️ Cause of post-<a href="https://wisskomm.social/tags/COVID" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID</a> inflammatory shock in children identified: Reactivation of the Epstein-Barr virus appears to cause the rare condition <a href="https://wisskomm.social/tags/MISC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MISC</a>. The findings, uncovered by a team from <a href="https://wisskomm.social/tags/Charit%C3%A9Berlin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CharitéBerlin</a> & the DRFZ, have now been published in <a href="https://wisskomm.social/tags/Nature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Nature</a>. 💡 These insights open the door to new treatment methods, potentially not limited to MIS-C.👉 <a href="https://www.charite.de/en/service/press_reports/artikel/detail/cause_of_post_covid_inflammatory_shock_in_children_identified" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.charite.de/en/service/press_reports/artikel/detail/cause_of_post_covid_inflammatory_shock_in_children_identified</a><a href="https://wisskomm.social/tags/Charit%C3%A9Paper" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CharitéPaper</a> <a href="https://wisskomm.social/tags/Science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Science</a> <a href="https://wisskomm.social/tags/Research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Research</a> <a href="https://wisskomm.social/tags/Medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Medicine</a> <a href="https://wisskomm.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://wisskomm.social/tags/PIMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PIMS</a> <a href="https://wisskomm.social/tags/SARSCoV2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SARSCoV2</a> <a href="https://wisskomm.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID19</a> <a href="https://wisskomm.social/tags/corona" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#corona</a> <a href="https://threads.net/@nature.portfolio/" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@nature.portfolio</a>

Charité Berlin‼️ Ursache für Entzündungsschock bei Kindern nach <a href="https://wisskomm.social/tags/Corona" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Corona</a> aufgeklärt: Die als <a href="https://wisskomm.social/tags/PIMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PIMS</a> bekannte seltene Erkrankung wird offenbar durch eine Reaktivierung des Epstein-Barr-Virus ausgelöst. Das zeigt ein Team von <a href="https://wisskomm.social/tags/Charit%C3%A9Berlin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CharitéBerlin</a> & DRFZ jetzt in <a href="https://wisskomm.social/tags/Nature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Nature</a>. 💡 Die Erkenntnisse eröffnen neue Therapiemöglichkeiten, möglicherweise nicht nur für PIMS.👉 <a href="https://www.charite.de/service/pressemitteilung/artikel/detail/ursache_fuer_entzuendungsschock_bei_kindern_nach_corona_aufgeklaert" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.charite.de/service/pressemitteilung/artikel/detail/ursache_fuer_entzuendungsschock_bei_kindern_nach_corona_aufgeklaert</a><a href="https://wisskomm.social/tags/Charit%C3%A9Paper" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CharitéPaper</a> <a href="https://wisskomm.social/tags/Wissenschaft" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Wissenschaft</a> <a href="https://wisskomm.social/tags/Forschung" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Forschung</a> <a href="https://wisskomm.social/tags/Medizin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Medizin</a> <a href="https://wisskomm.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://wisskomm.social/tags/MISC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MISC</a> <a href="https://wisskomm.social/tags/SARSCoV2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SARSCoV2</a> <a href="https://wisskomm.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID19</a> <a href="https://threads.net/@nature.portfolio/" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@nature.portfolio</a>

Anti. 🐘[⚠️ on Meta!] <a href="https://mstdn.social/@marga_owski" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@marga_owski</a> reports that an old anti-histamine and stomach acid inhibitor drug called Cimetidin has helped her with ME/CFS. It sounds like it is especially effective if an EBV reactivation is involved.There need to be trials with this drug. But I do not think it will help in all LC phenotypes.I have looked for a H2 anti-histamine as well, but didn't find an approved one in Switzerland.⚠️ Meta-link: <a href="https://www.instagram.com/p/DGvGMngstsU/?img_index=4" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.instagram.com/p/DGvGMngstsU/?img_index=4</a><a href="https://en.wikipedia.org/wiki/Cimetidine" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://en.wikipedia.org/wiki/Cimetidine</a><a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LongCOVID</a> <a href="https://chaos.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://chaos.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MECFS</a>

Jessie (they/she) 🍓 🏳️‍⚧️ 🍉So as a few of my lovely followers know... Over the last 3 years, Ive been in training to become a healthcare practitioner.I'm super passionate about working in healthcare and was hoping to work with my other marginalised colleagues to improve the system when I qualified.Honestly? After catching <a href="https://mstdn.social/tags/COVID" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID</a> for the 3rd time recently, it reactivating my <a href="https://mstdn.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> , and causing a chest and strep throat infection... Im left wondering if I can even continue to do this safely anymore. <a href="https://mstdn.social/tags/disability" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#disability</a> <a href="https://mstdn.social/tags/disabled" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#disabled</a>

Jessie (they/she) 🍓 🏳️‍⚧️ 🍉Do any <a href="https://mstdn.social/tags/LongCovid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LongCovid</a> / <a href="https://mstdn.social/tags/Covid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Covid</a> folk here know anything about <a href="https://mstdn.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> / <a href="https://mstdn.social/tags/Mono" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Mono</a> ? I've heard after reading some research that EBV increases risks of neurodegenerative disorders, and given that I've recently caught EBV... Id like to avoid those problems.Is there any literature on what to do to reduce risks after catching EBV?

Tom KindlonExploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1435170/full" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1435170/full</a>Hashtags:<a href="https://a.gup.pe/u/longcovid" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@longcovid</a> <a href="https://disabled.social/tags/LongCovid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LongCovid</a> <a href="https://disabled.social/tags/PwLC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PwLC</a> <a href="https://disabled.social/tags/PostCovidSyndrome" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PostCovidSyndrome</a> <a href="https://disabled.social/tags/LC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LC</a> <a href="https://disabled.social/tags/PASC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PASC</a> <a href="https://disabled.social/tags/postcovid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#postcovid</a> <a href="https://disabled.social/tags/CovidBrain" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CovidBrain</a> <a href="https://a.gup.pe/u/covid19" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@covid19</a> <a href="https://disabled.social/tags/COVID%E3%83%BC19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVIDー19</a> <a href="https://disabled.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID19</a> <a href="https://disabled.social/tags/COVID" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID</a> <a href="https://disabled.social/tags/COVID_19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#COVID_19</a> <a href="https://disabled.social/tags/SARSCoV2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SARSCoV2</a> <a href="https://chirp.social/@novid" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@novid@chirp.social</a> <a href="https://disabled.social/tags/novid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#novid</a> <a href="https://a.gup.pe/u/novid" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@novid@a.gup.pe</a> <a href="https://disabled.social/tags/CovidIsNotOver" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CovidIsNotOver</a> <a href="https://disabled.social/tags/auscovid19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#auscovid19</a> <a href="https://a.gup.pe/u/auscovid19" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@auscovid19</a> <a href="https://disabled.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> 1/

datum (n=1)If <a href="https://zeroes.ca/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> triggers the production of a superantigenic spike protein from an endogenous human virus, (doi:10.4049/jimmunol.177.4.2056), wouldn't one preventative treatment be Cas9'ing that out?Or, germline treatment for descendants' sake?<a href="https://zeroes.ca/tags/hotTake" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hotTake</a>

Matt WillemsenThis New Blood Test Could Help Solve The Mystery of Multiple Sclerosis <a href="https://www.sciencealert.com/this-new-blood-test-could-help-solve-the-mystery-of-multiple-sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.sciencealert.com/this-new-blood-test-could-help-solve-the-mystery-of-multiple-sclerosis</a> <a href="https://mastodon.social/tags/health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#health</a> <a href="https://mastodon.social/tags/BloodTest" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#BloodTest</a> <a href="https://mastodon.social/tags/multiplesclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#multiplesclerosis</a> <a href="https://mastodon.social/tags/MS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MS</a> <a href="https://mastodon.social/tags/ImmuneResponse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ImmuneResponse</a> <a href="https://mastodon.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a>

genXcrone (she/her)[People living with multiple sclerosis (MS) had a stronger immune response to Epstein-Barr virus (EBV) than those without MS—but their response did not follow a specific pattern that could help highlight the disease’s origins, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.]<a href="https://www.hsph.harvard.edu/news/hsph-in-the-news/further-investigating-the-link-between-ms-and-epstein-barr/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.hsph.harvard.edu/news/hsph-in-the-news/further-investigating-the-link-between-ms-and-epstein-barr/</a><a href="https://fandom.garden/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://fandom.garden/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a>

Andrew GiffordBrief podcast re EBV - Epstein Barr Virus - its discovery and behaviours/inter-play with other disease processes:<a href="https://www.bbc.co.uk/sounds/play/p01w7k0p" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.bbc.co.uk/sounds/play/p01w7k0p</a>With thanks to Amy The Tonic, over on Substack for unearthing this gem; <a href="https://substack.com/@amythetonic" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://substack.com/@amythetonic</a><a href="https://mastodon.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://mastodon.social/tags/EpsteinBarrVirus" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EpsteinBarrVirus</a> <a href="https://mastodon.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MECFS</a> <a href="https://mastodon.social/tags/myalgicencephalomyelitis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#myalgicencephalomyelitis</a>

MEActNOW🤞🏼🤞🏼🤞🏼 PolyBio Research Foundation CLINICAL TRIAL to TEST IF two repurposed HIV ANTIVIRALS (Truvada and Maraviroc) CAN REDUCE SYMPTOM burden in partients with LongCOVID.<a href="https://mastodon.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://mastodon.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MECFS</a> <a href="https://mastodon.social/tags/LongCovid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#LongCovid</a> <a href="https://mastodon.social/tags/HIV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HIV</a><a href="https://polybio.org/projects/a-clinical-trial-of-repurposed-hiv-antivirals-in-longcovid/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://polybio.org/projects/a-clinical-trial-of-repurposed-hiv-antivirals-in-longcovid/</a>

Tom KindlonFrom ME Research UK: Epstein-Barr virus - has received much attention in ME/CFS research. While linked to the onset of ME/CFS, less is known - particularly in young people, about what happens to symptoms & severity over time in ME/CFS following EBV infection <a href="https://www.meresearch.org.uk/1-yr-follow-up-of-young-people-with-me-cfs-following-glandular-fever-ebv-infection/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.meresearch.org.uk/1-yr-follow-up-of-young-people-with-me-cfs-following-glandular-fever-ebv-infection/</a> <a href="https://disabled.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MECFS</a> <a href="https://disabled.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a><a href="https://a.gup.pe/u/mecfs" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@mecfs</a> <a href="https://disabled.social/tags/MEcfs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MEcfs</a> <a href="https://disabled.social/tags/CFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CFS</a> <a href="https://disabled.social/tags/PwME" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PwME</a> <a href="https://disabled.social/tags/MyalgicEncephalomyelitis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MyalgicEncephalomyelitis</a> <a href="https://disabled.social/tags/ChronicFatigueSyndrome" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ChronicFatigueSyndrome</a>

RiffReporterDas Epstein-Barr-Virus kann die Autoimmunerkrankung Multiple Sklerose auslösen. Fast jeder Mensch trägt das Virus in sich, aber nur ein Bruchteil erkrankt an MS. Warum erklärt der Immunbiologe Hannes Vietzen im Interview mit <a href="https://mastodon.social/@UlrikeGebhardt" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@UlrikeGebhardt</a> (€) <a href="https://mastodon.social/tags/ebv" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ebv</a> <a href="https://mastodon.social/tags/medizin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medizin</a> <a href="https://mastodon.social/tags/ms" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ms</a> <a href="https://mastodon.social/tags/virus" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#virus</a> <a href="https://www.riffreporter.de/de/wissen/epstein-barr-virus-multiple-sklerose-immunabwehr-impfung-therapie" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.riffreporter.de/de/wissen/epstein-barr-virus-multiple-sklerose-immunabwehr-impfung-therapie</a>

Tom KindlonNew from Carmen Scheibenbogen team in Germany:One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus<a href="https://www.frontiersin.org/articles/10.3389/fped.2023.1266738/full" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.frontiersin.org/articles/10.3389/fped.2023.1266738/full</a><a href="https://disabled.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://disabled.social/tags/MyalgicEncephalomyelitis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MyalgicEncephalomyelitis</a> <a href="https://disabled.social/tags/ChronicFatigueSyndrome" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ChronicFatigueSyndrome</a> <a href="https://disabled.social/tags/MEcfs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MEcfs</a> <a href="https://disabled.social/tags/CFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CFS</a> <a href="https://disabled.social/tags/PwME" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PwME</a> <a href="https://a.gup.pe/u/mecfs" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@mecfs</a>

skry<a href="https://mastodon.social/tags/ebv" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ebv</a> <a href="https://mastodon.social/tags/ms" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ms</a> <a href="https://mastodon.social/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mstdn.social/@erictopol/111722894527596527" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://mstdn.social/@erictopol/111722894527596527</a>

Tom KindlonIgG Antibody Responses to Epstein-Barr Virus in <a href="https://disabled.social/tags/MyalgicEncephalomyelitis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MyalgicEncephalomyelitis</a> / <a href="https://disabled.social/tags/ChronicFatigueSyndrome" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ChronicFatigueSyndrome</a>: Their Effective Potential for Disease Diagnosis and Pathological Antigenic MimicryFree: <a href="https://www.preprints.org/manuscript/202311.1523/v1" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.preprints.org/manuscript/202311.1523/v1</a><a href="https://disabled.social/tags/MEcfs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MEcfs</a> <a href="https://disabled.social/tags/CFS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CFS</a> <a href="https://disabled.social/tags/PwME" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PwME</a> <a href="https://disabled.social/tags/MyalgicE" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MyalgicE</a> <a href="https://disabled.social/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://a.gup.pe/u/mecfs" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@mecfs</a>

Craig GroeschelWas doing some online research last night and ran across this article from 2020 talking about how spironolactone, a 50 y.o. drug used to treat hypokalemia, hypertension, and CHF targets an Epstein-Barr virus protein that is key to its replication. <a href="https://zeroes.ca/tags/EBV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EBV</a> <a href="https://zeroes.ca/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#antiviral</a><a href="https://pubmed.ncbi.nlm.nih.gov/26976570/" rel="nofollow noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/26976570/</a><a href="https://attheu.utah.edu/facultystaff/a-new-way-to-control-epstein-barr-virus/" rel="nofollow noopener noreferrer" target="_blank">https://attheu.utah.edu/facultystaff/a-new-way-to-control-epstein-barr-virus/</a>

Recent searches

Search options

Administered by:

Server stats: